Sana Biotechnology, Inc. Common Stock (SANA)
Sana Biotechnology, Inc. focuses on developing regenerative medicine and gene therapy solutions. The company aims to create and deliver engineered cells as medicines for various diseases, utilizing advancements in cell engineering and gene editing technologies to treat conditions with unmet medical needs.
Company News
Stock promoter Eric Jackson highlighted Sana Biotechnology as a potential '100-bagger' stock, citing falling interest rates, cooling inflation, and biotech sector revival as key catalysts.
Quell Therapeutics has formed a Scientific Advisory Board comprising leading experts in immunology, T-regulatory cell biology, and autoimmune diseases to guide its innovative CAR-Treg cell therapy development.
Notable companies to have witnessed solid earnings acceleration as of now are Sana Biotechnology (SANA), LifeMD (LFMD), Evolus (EOLS) and Expro Group Holdings (XPRO).
Good news drove shares of these stocks through the roof last week, but investors should be more concerned about their paths forward.